27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Neumora Therapeutics, Inc (NASDAQ:NMRA) IPO will take place September, 15 on the NASDAQ exchange under the ticker NMRA.
The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 13, 2024.
See also: Benzinga IPO Calendar
About Neumora Therapeutics, Inc
Neumora Therapeutics, Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!